Helix has introduced new clinico-genomic datasets built through data gathered by its healthcare partnerships, spanning multiple therapeutic areas, including cardiovascular, immunology, inflammation, and metabolic conditions.
Helix's precision cohorts combine longitudinal clinical data with Exome+ sequencing data, gathered from over 125,000 patients throughout the US. With regular updates of its databases, Helix's partners receive access to structured EHR fields, including clinical diagnosis, procedures, lab results, and prescriptions. The company claims that incorporating clinico-genomic datasets can help life sciences researchers discern genetic factors related to disease progression and clinical outcomes, validate therapeutic candidates more efficiently, and devise targeted therapies with improved safety and efficacy.
Helix is a genomics company specializing in DNA sequencing, bioinformatics, and personalized genomics products. It integrates genomic data into clinical care and research, offering DNA-powered products for various applications, including health, wellness, and ancestry. The company collaborates with various healthcare providers to enable population genomics and support scientific discoveries by providing insights into genetic data.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.